Related Experiment Video
Updated: Feb 3, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Antiapoptotic Molecule Survivin in Transplantation: Helpful or Harmful?
Sara Assadiasl1, Mohammad Javad Mousavi2,3, Aliakbar Amirzargar1,2
1Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Survivin, an antiapoptotic molecule from inhibitor of apoptosis protein (IAP) family, is most known for its implication in cancer as there are some efforts to apply it for diagnostic as well as therapeutic purposes in oncology. On the other hand, it could be a useful molecule to be positively targeted when trying to save tissue and promote cells viability. Since protecting the allograft from ischemia reperfusion injury and inflammation-induced damage is a considerable objective in transplantation, it is reasonable to take advantage from antiapoptotic agents like survivin in order to achieve this goal. However, survivin's potential ability to induce malignancies makes some concerns about its use in clinic. The other barrier is this molecule's involvement in lymphocytes development and proliferation which might increase the risk of graft rejection due to adaptive immune system overactivation. In this review we summarize the few studies carried out about survivin's effect on graft survival and probable advantages and disadvantages of its overexpression in transplantation.
Insights
Survivin, an anti-apoptotic protein, shows potential for improving graft survival in transplantation by protecting tissues from damage. However, concerns exist regarding its cancer-inducing risks and impact on immune rejection.
Area of Science:
- Biochemistry
- Immunology
- Transplantation Science
Background:
- Survivin is an antiapoptotic protein belonging to the inhibitor of apoptosis protein (IAP) family.
- It is recognized for its role in cancer, with therapeutic and diagnostic applications explored in oncology.
- Survivin's cytoprotective properties suggest potential benefits in preserving tissue viability.
Purpose of the Study:
- To review the existing studies on survivin's effects on graft survival.
- To evaluate the potential advantages of using survivin in transplantation.
- To identify the disadvantages and risks associated with survivin overexpression in transplant contexts.
Main Methods:
- Literature review of studies investigating survivin in transplantation.
- Analysis of survivin's role in protecting allografts from ischemia reperfusion injury and inflammation.
- Assessment of survivin's impact on immune responses, including lymphocyte development and proliferation.
Main Results:
- Survivin demonstrates potential in protecting transplanted organs from damage.
- Concerns regarding survivin's oncogenic potential and its influence on adaptive immunity are highlighted.
- The molecule's involvement in lymphocyte proliferation may increase the risk of graft rejection.
Conclusions:
- Survivin presents a dual role in transplantation, offering cytoprotection but posing risks of malignancy and immune rejection.
- Further research is needed to balance the benefits and risks of survivin application in clinical transplantation.
- Careful consideration of survivin's impact on both the graft and the host immune system is crucial for its therapeutic use.
Related Concept Videos
Molecules and Compounds
Types of Signaling Molecules
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Positive Regulator Molecules
Positive Regulator Molecules

